IRIS
MARAFINI, IRENE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.379
AS - Asia 2.983
EU - Europa 1.841
Continente sconosciuto - Info sul continente non disponibili 443
SA - Sud America 386
AF - Africa 39
OC - Oceania 4
Totale 20.075
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.251
SG - Singapore 1.547
IT - Italia 517
CN - Cina 510
BR - Brasile 317
HK - Hong Kong 284
RU - Federazione Russa 276
DE - Germania 198
BD - Bangladesh 178
IE - Irlanda 178
VN - Vietnam 162
UA - Ucraina 120
GB - Regno Unito 110
FI - Finlandia 97
FR - Francia 96
SE - Svezia 74
JP - Giappone 71
CA - Canada 59
KR - Corea 48
PL - Polonia 44
IN - India 39
NL - Olanda 35
MX - Messico 25
ID - Indonesia 22
AT - Austria 20
IQ - Iraq 20
TR - Turchia 19
AR - Argentina 18
ES - Italia 17
EC - Ecuador 14
JM - Giamaica 13
BE - Belgio 12
ZA - Sudafrica 12
CL - Cile 11
CO - Colombia 11
LT - Lituania 11
SA - Arabia Saudita 8
UZ - Uzbekistan 8
CR - Costa Rica 7
MA - Marocco 7
MY - Malesia 7
PH - Filippine 6
PK - Pakistan 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
EG - Egitto 5
GR - Grecia 5
IL - Israele 5
IR - Iran 5
JO - Giordania 5
TN - Tunisia 5
A1 - Anonimo 4
AU - Australia 4
BG - Bulgaria 4
NP - Nepal 4
PA - Panama 4
VE - Venezuela 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
HN - Honduras 3
HR - Croazia 3
KZ - Kazakistan 3
LB - Libano 3
NO - Norvegia 3
RO - Romania 3
AM - Armenia 2
BB - Barbados 2
BO - Bolivia 2
BS - Bahamas 2
KE - Kenya 2
LK - Sri Lanka 2
LV - Lettonia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SV - El Salvador 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BY - Bielorussia 1
CV - Capo Verde 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GI - Gibilterra 1
GT - Guatemala 1
GY - Guiana 1
HT - Haiti 1
HU - Ungheria 1
KG - Kirghizistan 1
MM - Myanmar 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 19.636
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.134
Wilmington 2.922
Houston 2.767
Singapore 724
Fairfield 525
Ashburn 503
San Jose 422
Council Bluffs 298
Ann Arbor 295
Hong Kong 282
Chandler 268
Seattle 230
Cambridge 180
Beijing 178
Rome 173
Dublin 150
Santa Clara 140
Medford 121
Los Angeles 120
New York 104
Jacksonville 96
The Dalles 94
Dearborn 84
Tokyo 65
Milan 60
Monte Vista 58
Chicago 57
Buffalo 55
Helsinki 55
Lawrence 55
Ho Chi Minh City 51
Lauterbourg 51
Dallas 45
North Charleston 38
Hanoi 36
Moscow 36
San Diego 33
Zhengzhou 32
Atlanta 26
North Bergen 26
Nuremberg 26
São Paulo 24
Menlo Park 23
Phoenix 23
Indianapolis 21
Kraków 21
London 20
Warsaw 20
Rio de Janeiro 19
Boardman 18
Toronto 18
Brooklyn 17
Colorado Springs 17
Munich 17
Redondo Beach 17
Shanghai 17
Chennai 16
Denver 16
Naples 15
Seoul 14
Frankfurt am Main 13
Miami 13
Orem 13
Baghdad 12
Bologna 12
Brussels 12
Jakarta 12
Montreal 12
San Francisco 12
Lappeenranta 11
Columbus 10
Groningen 10
Norwalk 10
Redwood City 10
Vienna 9
Curitiba 8
Da Nang 8
Johannesburg 8
Kunming 8
Manchester 8
Mexico City 8
Orlando 8
Philadelphia 8
Stockholm 8
Tashkent 8
Amsterdam 7
Bari 7
Belo Horizonte 7
Boston 7
Del Norte 7
Kingston 7
Mountain View 7
Reading 7
Salt Lake City 7
Ankara 6
Birmingham 6
Brescia 6
Charlotte 6
Chittagong 6
City of London 6
Totale 15.318
Salva come PNG Salva come JPEG
Nome #
Pyoderma gangrenosum in refractory celiac disease: a case report 621
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 549
Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet 537
Interleukin-34 sustains inflammatory pathways in the gut 525
TNF-α producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice 499
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 489
High Smad7 sustains inflammatory cytokine response in refractory coeliac disease 485
Smad7 knockdown restores aryl hydrocarbon receptor-mediated protective signals in the gut 483
The dual role of Smad7 in the control of cancer growth and metastasis 482
An overview of the role of innate lymphoid cells in gut infections and inflammation 473
Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients 470
Celiac disease-related inflammation is marked by reduction of Nkp44/Nkp46-double positive natural killer cells 467
Interleukin-34 induces Cc-chemokine ligand 20 in gut epithelial cells 465
Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies 464
Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease 463
TGF-Beta signaling manipulation as potential therapy for IBD 462
Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut 461
Antisense approach to inflammatory bowel disease: Prospects and challenges 457
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide 456
Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities 444
null 442
Defective expression of scavenger receptors in celiac disease mucosa 438
The TGF-β/Smad System in IBD Pathogenesis 422
The IL-12/23/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in Man 416
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation 395
Targeting integrins and adhesion molecules to combat inflammatory bowel disease 394
Smad7 positively regulates keratinocyte proliferation in psoriasis 390
Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad 383
Proteinase activated-receptors-associated signaling in the control of gastric cancer 368
Sodium chloride-enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice 336
The fragile X mental retardation protein regulates RIP1K and colorectal cancer resistance to necroptosis 271
Neutrophil extracellulartraps sustain inflammatory signals in ulcerative colitis 267
Precision Medicine in Inflammatory Bowel Diseases 253
Extent of mucosal inflammation in ulcerative colitis influences the clinical remission induced by vedolizumab 240
Inflammatory cytokines: from discoveries to therapies in IBD 231
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation 217
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease 202
Association between celiac disease and cancer 158
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 152
NPD-0414-2 and NPD-0414-24, two chemical entities designed as aryl hydrocarbon receptor (AHR) ligands, inhibit gut inflammatory signals 150
GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation 143
High frequency of undiagnosed psychiatric disorders in inflammatory bowel diseases 139
Novel therapeutic options for people with ulcerative colitis: an update on recent developments with Janus Kinase (JAK) inhibitors 131
An essential role of adenosine deaminase acting on RNA 1 in coeliac disease mucosa 127
Respiratory Tract Infections in Inflammatory Bowel Disease Patients Taking Vedolizumab: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 123
Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders 123
Involvement of smad7 in inflammatory diseases of the gut and colon cancer 123
The Deubiquitinating Enzyme OTUD5 Sustains Inflammatory Cytokine Response in Inflammatory Bowel Disease 114
Niclosamide enema for active distal ulcerative colitis: a phase I, open-label study 113
Preventable predictive factors of post-colonoscopy colorectal cancer in inflammatory bowel disease 101
Effect of Vedolizumab on anemia of chronic disease in patients with inflammatory bowel diseases 101
Low frequency of COVID-19 in inflammatory bowel diseases 99
Loss of Adenosine Deaminase Acting on RNA 1 Induces Panoptosis and Immune Response in Ulcerative Colitis Gut Mucosa 90
Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease 87
Inhomogeneous Diastereomeric Composition of Mongersen Antisense Phosphorothioate Oligonucleotide Preparations and Related Pharmacological Activity Impairment 87
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer 86
Metalloproteinases in inflammatory bowel diseases 86
Immune-mediated inflammatory diseases: Common and different pathogenic and clinical features 81
Interleukin-34 promotes tumorigenic signals for colon cancer cells 80
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms 75
Long-Term Risk of Colectomy in Patients with Severe Ulcerative Colitis Responding to Intravenous Corticosteroids or Infliximab 73
Frequency of dysplasia in endoscopically resected pseudopolyps in inflammatory bowel diseases 72
Frequency and Predictors of Dysplasia in Pseudopolyp-like Colorectal Lesions in Patients with Long-Standing Inflammatory Bowel Disease 70
Long-term outcomes and predictive factors of hospitalized patients with severe ulcerative colitis treated with intravenous corticosteroids 70
Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease 66
Endoscopic Predictors of Neoplastic Lesions in Inflammatory Bowel Diseases Patients Undergoing Chromoendoscopy 66
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer 64
Natural History of Ulcerative Colitis with Coexistent Colonic Diverticulosis. 64
Severe acute respiratory syndrome coronavirus 2 infection does not worsen the course of inflammatory bowel disease in the long term 63
Aryl Hydrocarbon Receptor Signalling in the Control of Gut Inflammation 63
Best of UEG Week 2024 62
Clinical outcome after entero-enteric anastomosis for Crohn’s disease: a case-control study 62
No effect of a liquid diet in the management of patients with stricturing Crohn’s disease 61
Reversibility of Frail Phenotype in Patients with Inflammatory Bowel Diseases 61
Paradoxical hidradenitis suppurativa in Crohn's disease patients receiving infliximab: a case report and review of literature 58
Gut microbiota analysis in inflammatory bowel disease: Novel findings from old data 54
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate? 54
Smoking and colorectal cancer in inflammatory bowel disease: Quantity matters? 50
High Smad7 marks inflammation in patients with chronic pouchitis 49
Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice 49
Inflammatory Bowel Disease Patients with a History of Cancer: Safety of Immunomodulators in a Multicenter Study 48
Longitudinal Evidence of Sustained Taurine Deficiency in Inflammatory Bowel Disease 45
Vedolizumab and new‐onset spondyloarthritis: Debunking the myth 45
Oligonucleotide-Based Therapies for Inflammatory Bowel Disease 40
Quality of clinical guidelines: It matters as it impacts patient care 37
Treatment options for refractory ulcerative colitis: Small molecules, big effects 36
Development and validation of the IBD frailty score in a multicenter prospective cohort of IBD outpatients 36
Redox Modulation in Hepatic Fibrosis: Translating NOX1/4 Inhibition to Therapy 36
Inhibiting Oxidative Phosphorylation In Vivo Restrains Th17 Effector Responses and Ameliorates Murine Colitis 34
Immune cell dynamics and mechanisms of epithelial injury in celiac disease 31
Inflammatory bowel disease: new therapies from antisense oligonucleotides 27
CD19 CAR T-Cell Therapy for Refractory Ulcerative Colitis 27
A Contagious Cause of Rectal Bleeding: Misleading Presentation of Chlamydia trachomatis Infection 25
Understanding Frailty in IBD: Implications for Clinical Outcomes and Multidisciplinary Care 25
Reduced Taurine Serum Levels in Inflammatory Bowel Disease 24
Molecular Insights into Helicobacter pylori-Induced Gastritis and Gastric Cancer 24
Optimizing Drug Positioning in IBD: Clinical Predictors, Biomarkers, and Practical Approaches to Personalized Therapy 22
Protective Effects of Aryl Hydrocarbon Receptor Signaling in Celiac Disease Mucosa and in Poly I:C-Induced Small Intestinal Atrophy Mouse Model 22
TGF-?? activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseases 21
Bromodomain-containing protein 4 in inflammatory diseases: molecular mechanisms and therapeutic potential 21
Totale 19.843
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.997
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022530 0 0 23 23 8 45 24 16 131 61 55 144
2022/2023662 64 77 16 85 60 150 61 34 48 21 29 17
2023/2024280 33 5 13 7 20 48 22 53 4 5 17 53
2024/20252.416 34 398 330 130 52 241 130 82 194 213 364 248
2025/20264.143 310 157 383 272 346 125 512 399 434 347 611 247
2026/2027871 377 287 207 0 0 0 0 0 0 0 0 0
Totale 20.075